• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    60 Biggest Movers From Yesterday

    4/26/22 4:58:37 AM ET
    $AGE
    $ARDX
    $ATER
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGE alert in real time by email

    Gainers

    • Nkarta, Inc. (NASDAQ:NKTX) shares climbed 140.9% to close at $18.72 on Monday after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.
    • ION Geophysical Corporation (NYSE:IO) gained 46.3% to close at $0.6880 on above-average volume.
    • Cango Inc. (NYSE:CANG) shares rose 40.7% to close at $3.32. Cango, last month, reported worse-than-expected Q4 EPS and sales results.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 40.6% to settle at $1.87 on above-average volume.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) shares gained 37.7% to close at $1.68. Erytech Pharma recently announced publication of results from Eryapasse Phase 2 trial as treatment for hypersensitive ALL in the British Journal of Haematology.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) climbed 37.5% to settle at $3.92.
    • Ardelyx, Inc. (NASDAQ:ARDX) climbed 31.8% to close at $0.9859 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal of the Complete Response Letter for XPHOZAH.
    • GWG Holdings, Inc. (NASDAQ:GWGH) jumped 31.1% to close at $2.99.
    • ImmuCell Corporation (NASDAQ:ICCC) gained 29% to settle at $10.71.
    • ImmuCell recently said it sees preliminary FY22 sales of $21.1 million.
    • Veru Inc. (NASDAQ:VERU) gained 25.8% to close at $14.10. Veru highlighted presentation of Phase 2 Sabizabulin at the 32nd European Congress of Clinical Microbiology & Infectious Diseases.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) rose 20.4% to close at $4.01 after the company reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
    • Swvl Holdings Corp. (NASDAQ:SWVL) shares rose 18.6% to close at $7.67 after the company announced its agreement to acquire Volt Lines.
    • Cabaletta Bio, Inc. (NASDAQ:CABA) jumped 18.6% to settle at $1.59.
    • RiceBran Technologies (NASDAQ:RIBT) surged 18.3% to close at $0.6287.
    • iCAD, Inc. (NASDAQ:ICAD) rose 18.2% to close at $3.57.
    • BigBear.ai Holdings, Inc. (NASDAQ:BBAI) gained 18.1% to close at $10.10.
    • AgeX Therapeutics, Inc. (NYSE:AGE) jumped 17.7% to settle at $1.00. AgeX Therapeutics, last month, reported Q4 earnings results.
    • CinCor Pharma, Inc. (NASDAQ:CINC) surged 17.3% to close at $25.48.
    • Aterian, Inc. (NASDAQ:ATER) climbed 16.4% to settle at $5.11.
    • IT Tech Packaging, Inc. (NYSE:ITP) shares rose 16.4% to close at $0.33. IT Tech Packaging, last monthm said Q4 EPS and sales results were higher year over year.
    • INmune Bio, Inc. (NASDAQ:INMB) gained 16.2% to settle at $7.96.
    • Sky Harbour Group Corporation (NASDAQ:SKYH) jumped 16% to close at $9.29.
    • DatChat, Inc. (NASDAQ:DATS) rose 15.7% to close at $1.99.
    • Zymergen Inc. (NASDAQ:ZY) gained 15.2% to settle at $2.05.
    • Dogness (International) Corporation (NASDAQ:DOGZ) gained 15.1% to close at $4.04.
    • PaySign, Inc. (NASDAQ:PAYS) rose 13.5% to settle at $1.93.
    • Silicon Motion Technology Corporation (NASDAQ:SIMO) gained 12.9% to close at $87.02 after Bloomberg reported that the company exploring a potential sale amid takeover interest.
    • PetVivo Holdings, Inc. (NASDAQ:PETV) gained 12.7% to close at $2.22.
    • PS Business Parks, Inc. (NYSE:PSB) climbed 11.8% to close at $187.50 after the company announced it will be acquired by affiliates of Blackstone Real Estate for $7.6 billion.
    • Cenntro Electric Group Limited (NASDAQ:CENN) gained 10.6% to settle at $1.88 after gaining around 7% on Friday.
    • BioLife Solutions, Inc. (NASDAQ:BLFS) rose 9.5% to close at $13.79. Oppenheimer upgraded BioLife Solns from Perform to Outperform and announced a $28 price target.
    • Joby Aviation, Inc. (NYSE:JOBY) jumped 6.8% to close at $5.31.
    • Graphite Bio, Inc. (NASDAQ:GRPH) gained 6.8% to settle at $4.27.
    • Eros STX Global Corporation (NYSE:ESGC) rose 6.7% to close at $2.39.

     

    Losers

    • Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) shares dipped 56.2% to settle at $0.7889 on Monday. Clarus Therapeutics reporetd pricing of upsized underwritten public offering at $1.10 per share.
    • Eliem Therapeutics, Inc. (NASDAQ:ELYM) shares tumbled 55.8% to close at $2.88 on Monday after the company announced the Phase 2a clinical trial of ETX-810 in diabetic peripheral neuropathic pain did not achieve the primary endpoint. The company also announced it elected to delay enrollment of its Phase 2a clinical trials of ETX-155 in major depressive disorder and perimenopausal depression.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) fell 44.9% to close at $14.57. ToughBuilt Industries reported a 1-for-150 reverse stock split as part of Nasdaq compliance plan.
    • Avadel Pharmaceuticals plc (NASDAQ:AVDL) dipped 36% to settle at $4.21. Avadel Pharmaceuticals announced interim data from the open-label RESTORE study at the 2022 American Academy of Neurology Annual Meeting.
    • Cypress Environmental Partners, L.P. (NYSE:CELP) fell 34.5% to close at $0.4212 after the company said an affiliate of Argonaut Private Equity has acquired 100% of Cypress’s senior secured debt from the seven existing lenders.
    • Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ:BHAT) fell 26.4% to close at $0.3267 on above-average volume.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) fell 25.6% to close at $0.7890.
    • Axsome Therapeutics, Inc. (NASDAQ:AXSM) dropped 22% to close at $30.50 after the company reported it was informed by the FDA that chemistry, manufacturing, and control issues identified during the FDA's review of its NDA for its AXS-07 product candidate are unresolved.
    • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) fell 20.5% to close at $0.9620.
    • FingerMotion, Inc. (NASDAQ:FNGR) declined 20.2% to close at $2.10.
    • EuroDry Ltd. (NASDAQ:EDRY) fell 19.1% to close at $32.21. EuroDry recently announced plans to acquire M/V Santa Cruz Bulker for $15.75 million.
    • Pineapple Energy Inc. (NASDAQ:PEGY) dipped 17.1% to settle at $3.35.
    • Brickell Biotech, Inc. (NASDAQ:BBI) fell 17% to settle at $0.2615.
    • Navios Maritime Holdings Inc. (NYSE:NM) dropped 15.4% to close at $3.73.
    • Bone Biologics Corporation (NASDAQ:BBLG) fell 14.8% to settle at $2.02.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) fell 14.4% to close at $1.94. Vallon Pharmaceuticals shares jumped more than 100% on Friday after the company announced a review of strategic alternatives.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) dropped 14.1% to close at $1.34.
    • Leju Holdings Limited (NYSE:LEJU) fell 14% to settle at $0.43.
    • COMSovereign Holding Corp. (NASDAQ:COMS) fell 13.9% to settle at $0.3964.
    • Nordic American Tankers Limited (NYSE:NAT) dropped 12.5% to close at $2.44.
    • MedAvail Holdings, Inc. (NASDAQ:MDVL) dipped 12.4% to close at $2.3750.
    • HighPeak Energy, Inc. (NASDAQ:HPK) dropped 11.5% to close at $33.35.
    • Koninklijke Philips N.V. (NYSE:PHG) shares fell 11.3% to close at $26.91. Philips reported a first-quarter FY22 sales growth of 2.6% year-on-year to €3.9 billion.
    • Golden Ocean Group Limited (NASDAQ:GOGL) fell 10.9% to close at $11.66.
    • Cyngn Inc. (NASDAQ:CYN) fell 10% to close at $2.42 after climbing around 27% on Friday. Cyngn recently announced the official launch of DriveMod Kit, a turnkey autonomous vehicle solution.
    • TradeUP Global Corporation (NASDAQ:TUGC) dipped 7.3% to settle at $9.22.
    Get the next $AGE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGE
    $ARDX
    $ATER
    $AVDL

    CompanyDatePrice TargetRatingAnalyst
    Silicon Motion Technology Corporation
    $SIMO
    1/22/2026Outperform
    William Blair
    Ardelyx Inc.
    $ARDX
    1/9/2026Neutral → Overweight
    Piper Sandler
    Axsome Therapeutics Inc.
    $AXSM
    1/8/2026$204.00Overweight → Equal-Weight
    Morgan Stanley
    BigBear.ai Inc.
    $BBAI
    1/7/2026$6.00Overweight → Neutral
    Cantor Fitzgerald
    Veru Inc.
    $VERU
    12/18/2025$25.00Buy
    Canaccord Genuity
    Koninklijke Philips N.V. NY Registry Shares
    $PHG
    12/17/2025Sector Perform
    RBC Capital Mkts
    Joby Aviation Inc.
    $JOBY
    12/1/2025$10.00Sell
    Goldman
    Sky Harbour Group Corporation
    $SKYH
    10/27/2025$13.00Buy
    BTIG Research
    More analyst ratings

    $AGE
    $ARDX
    $ATER
    $AVDL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mccamish Mark Anthony gifted 67,025 units of Ordinary Shares and received a gift of 67,025 units of Ordinary Shares (SEC Form 4)

    4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)

    2/6/26 4:10:10 PM ET
    $AVDL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Mcaleenan Kevin covered exercise/tax liability with 48,691 shares, decreasing direct ownership by 4% to 1,165,294 units (SEC Form 4)

    4 - BigBear.ai Holdings, Inc. (0001836981) (Issuer)

    2/4/26 6:48:48 AM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    Officer Dehoff Kate converted options into 22,547 shares and sold $85,873 worth of shares (8,194 units at $10.48), increasing direct ownership by 10% to 163,722 units (SEC Form 4)

    4 - Joby Aviation, Inc. (0001819848) (Issuer)

    2/3/26 5:20:45 PM ET
    $JOBY
    Aerospace
    Industrials

    $AGE
    $ARDX
    $ATER
    $AVDL
    SEC Filings

    View All

    Sunshine Biopharma Inc. filed SEC Form 8-K: Leadership Update

    8-K - Sunshine Biopharma Inc. (0001402328) (Filer)

    2/5/26 4:16:20 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 144 filed by Axsome Therapeutics Inc.

    144 - Axsome Therapeutics, Inc. (0001579428) (Subject)

    2/2/26 5:30:05 PM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ImmuCell Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - IMMUCELL CORP /DE/ (0000811641) (Filer)

    2/2/26 5:22:50 PM ET
    $ICCC
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Medical Officer Chang David J. bought $19,888 worth of shares (8,800 units at $2.26) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:58 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President, Science & Tech. Binder Gwendolyn bought $24,763 worth of shares (11,312 units at $2.19), increasing direct ownership by 57% to 31,312 units (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:56:30 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Tomasello Shawn bought $50,322 worth of shares (22,725 units at $2.21) (SEC Form 4)

    4 - Cabaletta Bio, Inc. (0001759138) (Issuer)

    1/21/26 6:55:49 PM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated

    10/20/23 4:37:52 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZAH issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZAH (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:43:04 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for XPHOZA™ issued to ARDELYX INC

    Submission status for ARDELYX INC's drug XPHOZA™ (ORIG-1) with active ingredient TENAPANOR has changed to 'Approval' on 10/17/2023. Application Category: NDA, Application Number: 213931, Application Classification: Labeling

    10/18/23 4:37:08 PM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026

    PHILADELPHIA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (NASDAQ:CABA), a late-stage clinical biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the Company will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026 on Thursday, February 12, 2026, at 9:30 a.m. ET in New York, NY. A live webcast of the presentation will be available on the News and Events section of the Company's website at www.cabalettabio.com. Replays will be available on the website for 30 days. About Cabaletta BioCabaletta Bio (NASDAQ:CABA) is a

    2/5/26 8:00:00 AM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026

    WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the full year and fourth quarter of 2025. The call will include commentary from members of the Ardelyx Executive Leadership Team including Mike Raab, President and Chief Executive Officer, Sue Hohenleitner, Chief Financial Officer, Eric Foster, Chief Commercial Officer, and Laura

    2/5/26 8:00:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Cyngn Advances Site-Wide Autonomy With DriveMod Tugger Operations Across Connected Facilities

    MOUNTAIN VIEW, Calif., Feb. 5, 2026 /PRNewswire/ -- Cyngn Inc. (NASDAQ:CYN) today highlighted continued expansion of DriveMod Tugger deployments across large, connected industrial facilities, reflecting growing customer demand for site-wide autonomy that supports end-to-end material movement. DriveMod is increasingly being used in workflows that span multiple buildings and outdoor transit corridors, helping organizations reduce bottlenecks, improve throughput consistency, and redeploy labor toward higher-value operations. As warehouses and manufacturing campuses grow larger—of

    2/5/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    $AGE
    $ARDX
    $ATER
    $AVDL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    William Blair initiated coverage on Silicon Motion

    William Blair initiated coverage of Silicon Motion with a rating of Outperform

    1/22/26 8:30:26 AM ET
    $SIMO
    Semiconductors
    Technology

    Ardelyx upgraded by Piper Sandler

    Piper Sandler upgraded Ardelyx from Neutral to Overweight

    1/9/26 8:23:44 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Axsome Therapeutics downgraded by Morgan Stanley with a new price target

    Morgan Stanley downgraded Axsome Therapeutics from Overweight to Equal-Weight and set a new price target of $204.00

    1/8/26 8:36:26 AM ET
    $AXSM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Leadership Updates

    Live Leadership Updates

    View All

    Cyngn Partners with Chandler Automation, Expands into Agriculture

    MOUNTAIN VIEW, Calif., Dec. 23, 2025 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced that Chandler Automation has joined its dealer network and will begin offering Cyngn's autonomous DriveMod Tugger to food processors and packers in the agriculture sector. Chandler Automation is a full-service partner in factory automation, specializing in optical sorting, inspection, robotic palletizing, and custom processing machinery. Known for delivering tailored, high-performance systems, Chandler empowers food processors to reduce labor costs, boost efficiency, and stay competitive wi

    12/23/25 7:00:00 AM ET
    $CYN
    EDP Services
    Technology

    Nordic American Tankers Ltd (NYSE: NAT) – Results of its 2025 Annual General Meeting

      Friday, November 21, 2025   Dear Shareholders and Investors,   Nordic American Tankers Limited (NYSE:NAT) conducted its Annual General Meeting of Shareholders (the "Meeting") today, on November 21, 2025. We experienced a very high turnout at this year's AGM and all resolutions were approved and adopted at the Meeting: Election of Herbjorn Hansson, Alexander Hansson, Jenny Chu and Jim Kelly to serve as Directors of the Board.Approval of the appointment of KPMG as the Company's independent auditors.  We are in a strong market and prospects are good. Sincerely, Herbjorn HanssonFounder, Chairman & CEO Nordic American Tankers Ltd.                                                   

    11/21/25 9:36:37 AM ET
    $NAT
    Marine Transportation
    Consumer Discretionary

    Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update

    Rese-cel data presented at multiple medical meetings demonstrated potentially transformative, drug-free clinical responses with a favorable safety profile for autoimmune patients supporting outpatient use All myositis patients in the Phase 1/2 DM/ASyS cohort with sufficient follow-up who would have met key criteria for the registrational cohort met the registrational, 16-week primary endpoint Planned BLA submission for rese-cel in 2027 based on 14-patient, single-arm DM/ASyS registrational cohort initiating enrollment this quarter within the RESET-Myositis™ trial FDA alignment on additional registrational cohort designs for RESET-SSc™ and RESET-SLE™ anticipated by year-end 2025 PHILADEL

    11/10/25 7:30:00 AM ET
    $CABA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Financials

    Live finance-specific insights

    View All

    Ardelyx to Report Full Year and Fourth Quarter 2025 Financial Results on February 19, 2026

    WALTHAM, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced it will hold a conference call on Thursday, February 19, 2026, at 4:30 p.m. Eastern Time to discuss financial results and provide a business update from the full year and fourth quarter of 2025. The call will include commentary from members of the Ardelyx Executive Leadership Team including Mike Raab, President and Chief Executive Officer, Sue Hohenleitner, Chief Financial Officer, Eric Foster, Chief Commercial Officer, and Laura

    2/5/26 8:00:00 AM ET
    $ARDX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th

    MIAMI, FL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it will host a conference call and audio webcast on Wednesday, February 11, 2026, at 8:00 a.m. ET to discuss its fiscal 2026 first quarter financial results and to provide a business update. The audio webcast will be accessible under the Home page and Investors page of the Company's website at www.verupharma.com. To join the conference call via telephone, please dial 1-800-341-1602 (domestic) or 1-412-902-6706 (international) and ask to join the Veru I

    2/4/26 8:30:00 AM ET
    $VERU
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Silicon Motion Announces Results for the Fourth Quarter and Year Ended December 31, 2025

    Business Highlights Fourth quarter of 2025 sales increased 15% Q/Q and increased 46% Y/Y SSD controller sales: 4Q of 2025 increased 25% to 30% Q/Q and increased 35% to 40% Y/YeMMC+UFS controller sales: 4Q of 2025 increased 0% to 5% Q/Q and increased 50% to 55% Y/YSSD solutions sales: 4Q of 2025 increased 125% to 130% Q/Q and increased 110% to 115% Y/Y Announced annual cash dividend of $2.00 per American Depositary Share ("ADS") Financial Highlights  4Q 2025 GAAP4Q 2025 Non-GAAP*•   Net sales$278.5 million (+15% Q/Q, +46% Y/Y)$278.5 million (+15% Q/Q, +46% Y/Y)•   Gross margin49.1%49.2%•   Operating margin11.4%19.3%•   Earnings per diluted ADS$1.41$1.26  Full Year 2025 GAAPFull Year 2025 N

    2/3/26 6:00:00 PM ET
    $SIMO
    Semiconductors
    Technology

    $AGE
    $ARDX
    $ATER
    $AVDL
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Breaking: Stock Acquired at INmune Bio Inc. on Jun 26

    Recently, on June 26, 2024, Director Juda Scott bought $36,350 worth of shares (5,000 units at $7.27) (SEC Form 4) in INmune Bio Inc. This insider purchase is significant as it indicates confidence from someone within the company towards its future growth prospects. It's interesting to note that this purchase by Juda Scott follows a series of transactions by other insiders in the company. For example, Moss David J bought $149,993 worth of shares (18,028 units at $8.32) on April 24, 2024, increasing direct ownership by 1% to 1,268,179 units. This demonstrates a consistent trend of insider buying within the organization. Looking back at previous transactions, on May 16, 2024, several key ins

    6/26/24 2:54:12 PM ET
    $INMB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGE
    $ARDX
    $ATER
    $AVDL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/16/24 9:09:02 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BigBear.ai Inc.

    SC 13D/A - BigBear.ai Holdings, Inc. (0001836981) (Subject)

    12/12/24 4:17:36 PM ET
    $BBAI
    Computer Software: Prepackaged Software
    Technology